{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:31Z","timestamp":1792267411107,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chroma.2026.467212","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:10:02Z","timestamp":1782400202000},"page":"467212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advances and perspectives in Oligo(dT) Affinity chromatography for mRNA capture: Resins, ligands and process intensification"],"prefix":"10.1016","volume":"1784","author":[{"given":"Xuena","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-103X","authenticated-orcid":false,"given":"Liming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2026.467212_bib0001","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.chroma.2026.467212_bib0002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014Developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.chroma.2026.467212_bib0003","unstructured":"National Institutes of Health. https:\/\/clinicaltrials.gov\/search?intr=mRNA (Accessed 24 January 2026)."},{"key":"10.1016\/j.chroma.2026.467212_bib0004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/d41573-021-00147-y","article-title":"Evolution of the market for mRNA technology","volume":"20","author":"Xie","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.chroma.2026.467212_bib0005","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.chroma.2026.467212_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18609\/nai.2024.033","article-title":"Process optimization of mRNA purification for vaccines and therapeutic applications","volume":"1","author":"Gaskin","year":"2024","journal-title":"Nucl. Acid Insights"},{"key":"10.1016\/j.chroma.2026.467212_bib0007","doi-asserted-by":"crossref","first-page":"489","DOI":"10.18609\/cgti.2021.073","article-title":"Supporting development of mRNA-based therapies by addressing large-scale purification challenges","volume":"7","author":"Flook","year":"2021","journal-title":"Cell Gene Ther. Insights."},{"key":"10.1016\/j.chroma.2026.467212_bib0008","first-page":"243","article-title":"Binding capacity and mechanism analysis of four Oligo(dT) affinity chromatography resins","volume":"38","author":"Tan","year":"2024","journal-title":"J. Chem. Eng. Chin. Univ."},{"key":"10.1016\/j.chroma.2026.467212_bib0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.chroma.2014.04.063","article-title":"Improving the binding capacities of protein A chromatographic materials by means of ligand polymerization","volume":"1347","author":"von Roman","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467212_bib0010","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/s41467-023-41354-y","article-title":"mRNA vaccine quality analysis using RNA sequencing","volume":"14","author":"Gunter","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chroma.2026.467212_bib0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/biomedicines10010050","article-title":"mRNA therapeutic modalities design, formulation and manufacturing under Pharma 4.0 principles","volume":"10","author":"Ouranidis","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.chroma.2026.467212_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001048","article-title":"Hydrophobic interaction: a promising driving force for the biomedical applications of nucleic acids","volume":"7","author":"Xiao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.chroma.2026.467212_bib0013","unstructured":"Purolite, Praesto Jetted (dT)18-DVB Affinity resin product datasheet, http:\/\/www.tinyblog.cn\/?p=4107 (Accessed 31 December 2025)."},{"key":"10.1016\/j.chroma.2026.467212_bib0014","unstructured":"Nanomicro Technology, instructions of NanoGel dT20, http:\/\/www.nanomicro.com\/product\/205.html?productCateId=112 (Accessed 31 December 2025)."},{"key":"10.1016\/j.chroma.2026.467212_bib0015","unstructured":"Sepax Technologies, Instructions of Proteomix POR50-dT20 Affinity Resin, https:\/\/www.sepax-tech.com.cn\/products\/progych\/proqh\/2023-03-17\/105.html (Accessed 31 December 2025)."},{"key":"10.1016\/j.chroma.2026.467212_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2022.122320","article-title":"Development and scale-up of oligo-dT monolithic chromatographic column for mRNA capture through understanding of base-pairing interactions","volume":"304","author":"Mencin","year":"2023","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.chroma.2026.467212_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.chroma.2026.467212_bib0018","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nsmb.2703","article-title":"The human cap-binding complex is functionally connected to the nuclear RNA exosome","volume":"20","author":"Andersen","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chroma.2026.467212_bib0019","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1360\/TB-2023-1013","article-title":"Purification of IVT mRNA by 5\u2032 cap affinity chromatography (in Chinese)","volume":"69","author":"Du","year":"2024","journal-title":"Chin. Sci. Bull."},{"key":"10.1016\/j.chroma.2026.467212_bib0020","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1073\/pnas.1232347100","article-title":"Purifying mRNAs with a high-affinity eIF4E mutant identifies the short 3\u2032 poly(A) end phenotype","volume":"100","author":"Choi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.chroma.2026.467212_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465454","article-title":"Pore structure reconstruction to reveal the adsorption capacity limitation of current oligo-dT resins and guide new resin design","volume":"1737","author":"Qiao","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467212_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3301","article-title":"Comprehensive studies on building a scalable downstream process for mRNAs to enable mRNA therapeutics","volume":"39","author":"Cui","year":"2023","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chroma.2026.467212_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464670","article-title":"Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent","volume":"1717","author":"Dewar","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467212_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2024.129310","article-title":"Convection rather than diffusion for fast efficient mRNA vaccine purification","volume":"354","author":"Banik","year":"2025","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.chroma.2026.467212_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/aic.70068","article-title":"Digital design of chromatographic resins to improve mass transfer for large biomolecules: an exploration of concept","volume":"72","author":"Qiao","year":"2026","journal-title":"AlChE J."},{"key":"10.1016\/j.chroma.2026.467212_bib0026","series-title":"Ph.D. Thesis","article-title":"CFD optimization of biological processes and manufacturing methods with a final focus on rethinking classical cellulose oligo(dT) mRNA purification for next-generation mRNA therapeutics","author":"Marx","year":"2025"},{"key":"10.1016\/j.chroma.2026.467212_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2023.109213","article-title":"Enhanced adsorption performance of varying-length mRNA on Oligo dT affinity resins through optimal pore size and grafting","volume":"203","author":"Tan","year":"2024","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.chroma.2026.467212_bib0028","unstructured":"J. England, Scalable mRNA affinity capture: supporting development and production of mRNA-based therapeutics, Available at: https:\/\/www.bioprocessintl.com\/sponsored-content\/scalable-mrna-affinity-capture-supporting-development-and-production-of-mrna-based-therapeutics (Accessed 31 December 2025)."},{"key":"10.1016\/j.chroma.2026.467212_bib0029","first-page":"44","article-title":"Increasing dynamic binding capacity of oligo(dT) for mRNA purification: experimental results using CIM 96-well plates","volume":"20","author":"Mencin","year":"2022","journal-title":"Bioprocess. Int."},{"key":"10.1016\/j.chroma.2026.467212_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102333","article-title":"Quality by design for mRNA platform purification based on continuous oligo-dT chromatography","volume":"35","author":"Qu","year":"2024","journal-title":"Mol. Ther.-Nucl. Acids"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326005418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326005418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:07:37Z","timestamp":1786018057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967326005418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0021967326005418"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467212","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and perspectives in Oligo(dT) Affinity chromatography for mRNA capture: Resins, ligands and process intensification","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"467212"}}